{"PubmedArticle": [{"MedlineCitation": {"OtherID": [], "SpaceFlightMission": [], "KeywordList": [["ONJ", "osteonecrosis", "staging", "surgery", "therapy", "treatment"]], "CitationSubset": ["IM"], "InvestigatorList": [], "OtherAbstract": [], "GeneralNote": [], "PMID": "34444181", "DateCompleted": {"Year": "2021", "Month": "09", "Day": "03"}, "DateRevised": {"Year": "2022", "Month": "05", "Day": "31"}, "Article": {"Language": ["eng"], "ArticleDate": [{"Year": "2021", "Month": "08", "Day": "10"}], "ELocationID": ["8432", "10.3390/ijerph18168432"], "Journal": {"ISSN": "1660-4601", "JournalIssue": {"Volume": "18", "Issue": "16", "PubDate": {"Year": "2021", "Month": "Aug", "Day": "10"}}, "Title": "International journal of environmental research and public health", "ISOAbbreviation": "Int J Environ Res Public Health"}, "ArticleTitle": "The Treatment of Medication-Related Osteonecrosis of the Jaw (MRONJ): A Systematic Review with a Pooled Analysis of Only Surgery versus Combined Protocols.", "Abstract": {"AbstractText": ["Medication-related osteonecrosis of the jaw (MRONJ) is a serious adverse reaction of antiresorptive and antiangiogenic agents, and it is also a potentially painful and debilitating condition. To date, no specific studies have prospectively evaluated the efficacy of its treatment and no robust standard of care has been established. Therefore, a systematic review (2007-2020) with a pooled analysis was performed in order to compare MRONJ surgical techniques (conservative or aggressive) versus combined surgical procedures (surgery plus a non-invasive procedure), where 1137 patients were included in the pooled analysis. A statistically significant difference in the 6-month improvement rate, comparing combined conservative surgery versus only aggressive (91% versus 72%, <i>p</i> = 0.05), was observed. No significant difference regarding any group with respect to the 6-month total resolution rate (82% versus 72%) was demonstrated. Of note, conservative surgery combined with various, adjuvant, non-invasive procedures (ozone, LLLT or blood component + Nd:YAG) was found to achieve partial or full healing in all stages, with improved results and the amelioration of many variables. In conclusion, specific adjuvant treatments associated with minimally conservative surgery can be considered effective and safe in the treatment of MRONJ, although well-controlled studies are a requisite in arriving at definitive statements."]}, "AuthorList": [{"Identifier": ["0000-0002-5562-7420"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Surgical, Oncological and Oral Sciences (Di.Chir.On.S.), University of Palermo, 90127 Palermo, Italy."}], "LastName": "Di Fede", "ForeName": "Olga", "Initials": "O"}, {"Identifier": ["0000-0001-9113-0182"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Operative Unit of Dentistry and Stomatology, Azienda Ospedaliera Ospedali Riuniti Villa Sofia Cervello, 90146 Palermo, Italy."}], "LastName": "Canepa", "ForeName": "Federica", "Initials": "F"}, {"Identifier": ["0000-0001-6339-6020"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Surgical, Oncological and Oral Sciences (Di.Chir.On.S.), University of Palermo, 90127 Palermo, Italy."}], "LastName": "Panzarella", "ForeName": "Vera", "Initials": "V"}, {"Identifier": ["0000-0002-4008-6502"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Surgical, Oncological and Oral Sciences (Di.Chir.On.S.), University of Palermo, 90127 Palermo, Italy."}, {"Identifier": [], "Affiliation": "Department of Biomedical and Dental Sciences and Morphofunctional Imaging, University of Messina, 98124 Messina, Italy."}, {"Identifier": [], "Affiliation": "Department of Dental Surgery, Faculty of Dental Surgery, University of Malta, MSD 2090 Msida, Malta."}], "LastName": "Mauceri", "ForeName": "Rodolfo", "Initials": "R"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Surgical, Oncological and Oral Sciences (Di.Chir.On.S.), University of Palermo, 90127 Palermo, Italy."}], "LastName": "Del Gaizo", "ForeName": "Carmine", "Initials": "C"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Regional Center for Prevention, Diagnosis and Treatment of Medication and Radiation-Related Bone Diseases of the Head and Neck, University of Padova, 35128 Padova, Italy."}], "LastName": "Bedogni", "ForeName": "Alberto", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Azienda Ospedaliera SS. Antonio e Biagio e Cesare Arrigo, 15121 Alessandria, Italy."}], "LastName": "Fusco", "ForeName": "Vittorio", "Initials": "V"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Operative Unit of Dentistry and Stomatology, Azienda Ospedaliera Ospedali Riuniti Villa Sofia Cervello, 90146 Palermo, Italy."}], "LastName": "Tozzo", "ForeName": "Pietro", "Initials": "P"}, {"Identifier": ["0000-0001-8119-4924"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Surgical, Oncological and Oral Sciences (Di.Chir.On.S.), University of Palermo, 90127 Palermo, Italy."}], "LastName": "Pizzo", "ForeName": "Giuseppe", "Initials": "G"}, {"Identifier": ["0000-0002-9443-0495"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Surgical, Oncological and Oral Sciences (Di.Chir.On.S.), University of Palermo, 90127 Palermo, Italy."}], "LastName": "Campisi", "ForeName": "Giuseppina", "Initials": "G"}, {"Identifier": ["0000-0003-4365-5683"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Surgical, Oncological and Oral Sciences (Di.Chir.On.S.), University of Palermo, 90127 Palermo, Italy."}], "LastName": "Galvano", "ForeName": "Antonio", "Initials": "A"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't", "Systematic Review"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Int J Environ Res Public Health", "NlmUniqueID": "101238455", "ISSNLinking": "1660-4601"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Bone Density Conservation Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Diphosphonates"}], "MeshHeadingList": [{"QualifierName": ["surgery", "therapy"], "DescriptorName": "Bisphosphonate-Associated Osteonecrosis of the Jaw"}, {"QualifierName": ["adverse effects"], "DescriptorName": "Bone Density Conservation Agents"}, {"QualifierName": [], "DescriptorName": "Diphosphonates"}, {"QualifierName": [], "DescriptorName": "Humans"}], "CoiStatement": "The authors declare no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript, apart from those disclosed."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Campisi G., Bedogni A., Fusco V. In: Raccomandazioni Clinico-Terapeutiche Sull\u2019osteonecrosi Delle Ossa Mascellari (ONJ) Farmaco-Relata e Sua Prevenzione. NDF S., editor. Palermo University Press; Palermo, Italy: 2020."}, {"Citation": "Ruggiero S.L., Mehrotra B., Rosenberg T.J., Engroff S.L. Osteonecrosis of the jaws associated with the use of bisphosphonates: A review of 63 cases. J. Oral Maxillofac. Surg. 2004;62:527\u2013534. doi: 10.1016/j.joms.2004.02.004.", "ArticleIdList": ["10.1016/j.joms.2004.02.004", "15122554"]}, {"Citation": "Khan A.A., Morrison A., Hanley D.A., Felsenberg D., McCauley L.K., O\u2019Ryan F., Reid I., Ruggiero S.L., Taguchi A., Tetradis S., et al. Diagnosis and Management of Osteonecrosis of the Jaw: A Systematic Review and International Consensus. J. Bone Miner. Res. 2015;30:3\u201323. doi: 10.1002/jbmr.2405.", "ArticleIdList": ["10.1002/jbmr.2405", "25414052"]}, {"Citation": "Kuroshima S., Sasaki M., Sawase T. Medication-Related Osteonecrosis of the Jaw: A Literature Review. J. Oral Biosciences. Jpn. Assoc. Oral Biology. 2019;61:99\u2013104. doi: 10.1016/j.job.2019.03.005.", "ArticleIdList": ["10.1016/j.job.2019.03.005", "31109863"]}, {"Citation": "Nicolatou-Galitis O., Schi\u00f8dt M., Mendes R.A., Ripamonti C., Hope S., Drudge-Coates L., Niepel D., Wyngaert T.V.D. Medication-related osteonecrosis of the jaw: Definition and best practice for prevention, diagnosis, and treatment. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. 2019;127:117\u2013135. doi: 10.1016/j.oooo.2018.09.008.", "ArticleIdList": ["10.1016/j.oooo.2018.09.008", "30393090"]}, {"Citation": "Campisi G., Fedele S., Fusco V., Pizzo G., di Fede O., Bedogni A. Epidemiology, clinical manifestations, risk reduction and treatment strategies of jaw osteonecrosis in cancer patients exposed to antiresorptive agents. Futur. Oncol. 2014;10:257\u2013275. doi: 10.2217/fon.13.211.", "ArticleIdList": ["10.2217/fon.13.211", "24490612"]}, {"Citation": "Schiodt M., Otto S., Fedele S., Bedogni A., Nicolatou-Galitis O., Guggenberger R., Herlofson B.B., Ristow O., Kofod T. Workshop of European task force on medication-related osteonecrosis of the jaw\u2014Current challenges. Oral Dis. 2019;25:1815\u20131821. doi: 10.1111/odi.13160.", "ArticleIdList": ["10.1111/odi.13160", "31325201"]}, {"Citation": "G\u00f3mez-Moreno G., Arribas-Fern\u00e1ndez M.C., Fern\u00e1ndez-Guerrero M., Castro A.B., Aguilar-Salvatierra A., Guardia J., Botticelli D., Calvo-Guirado J.L. Bisphosphonate-associated osteonecrosis of the jaw 2 years after teeth extractions: A case report solved with non-invasive treatment. Eur. Rev. Med. Pharmacol. Sci. 2014;18:1391\u20131397.", "ArticleIdList": ["24867519"]}, {"Citation": "Moretti F., Pelliccioni G.A., Montebugnoli L., Marchetti C. A prospective clinical trial for assessing the efficacy of a minimally invasive protocol in patients with bisphosphonate-associated osteonecrosis of the jaws. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endodontology. 2011;112:777\u2013782. doi: 10.1016/j.tripleo.2011.07.004.", "ArticleIdList": ["10.1016/j.tripleo.2011.07.004", "22000426"]}, {"Citation": "Bedogni A., Saia G., Bettini G., Tronchet A., Totola A., Bedogni G., Ferronato G., Nocini P.F., Blandamura S. Long-term outcomes of surgical resection of the jaws in cancer patients with bisphosphonate-related osteonecrosis. Oral Oncol. 2011;47:420\u2013424. doi: 10.1016/j.oraloncology.2011.02.024.", "ArticleIdList": ["10.1016/j.oraloncology.2011.02.024", "21439892"]}, {"Citation": "Beth-Tasdogan N.H., Mayer B., Hussein H., Zolk O. Interventions for managing medication-related osteonecrosis of the jaw. Cochrane Database Syst. Rev. 2017;10:CD012432. doi: 10.1002/14651858.CD012432.pub2.", "ArticleIdList": ["10.1002/14651858.CD012432.pub2", "PMC6485859", "28983908"]}, {"Citation": "Laimer J., Steinmassl O., Hechenberger M., Rasse M., Pikula R., Bruckmoser E. Intraoral Vacuum-Assisted Closure Therapy\u2014A Pilot Study in Medication-Related Osteonecrosis of the Jaw. J. Oral Maxillofac. Surg. 2017;75:2154\u20132161. doi: 10.1016/j.joms.2017.02.033.", "ArticleIdList": ["10.1016/j.joms.2017.02.033", "28396234"]}, {"Citation": "Owosho A.A., Estilo C.L., Huryn J.M., Yom S.K. Pentoxifylline and tocopherol in the management of cancer patients with medication-related osteonecrosis of the jaw: An observational retrospective study of initial case series. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. 2016;122:455\u2013459. doi: 10.1016/j.oooo.2016.06.019.", "ArticleIdList": ["10.1016/j.oooo.2016.06.019", "PMC5454806", "27651287"]}, {"Citation": "Magremanne M., Reychler H. Pentoxifylline and Tocopherol in the Treatment of Yearly Zoledronic Acid\u2013Related Osteonecrosis of the Jaw in a Corticosteroid-Induced Osteoporosis. J. Oral Maxillofac. Surg. 2014;72:334\u2013337. doi: 10.1016/j.joms.2013.06.188.", "ArticleIdList": ["10.1016/j.joms.2013.06.188", "23891014"]}, {"Citation": "Porcaro G., Amosso E., Scarpella R., Carini F. Doxycycline fluorescence-guided Er:YAG laser ablation combined with Nd:YAG/diode laser biostimulation for treating bisphosphonate-related osteonecrosis of the jaw. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. 2015;119:e6\u2013e12. doi: 10.1016/j.oooo.2014.04.014.", "ArticleIdList": ["10.1016/j.oooo.2014.04.014", "25174873"]}, {"Citation": "Luomanen M., Alaluusua S. Treatment of bisphosphonate-induced osteonecrosis of the jaws with Nd:YAG laser biostimulation. Lasers Med. Sci. 2011;27:251\u2013255. doi: 10.1007/s10103-011-0929-7.", "ArticleIdList": ["10.1007/s10103-011-0929-7", "21597949"]}, {"Citation": "Heggendorn F.L., Leite T.C., Cunha K.S.G., J\u00fanior A.S., Gon\u00e7alves L.S., Da Costa K.B.F.F., Dias E.P. Bisphosphonate-related osteonecrosis of the jaws: Report of a case using conservative protocol. Sp\u00e9c. Care Dent. 2016;36:43\u201347. doi: 10.1111/scd.12143.", "ArticleIdList": ["10.1111/scd.12143", "26782365"]}, {"Citation": "Yoshiga D., Yamashita Y., Nakamichi I., Tanaka T., Yamauchi K., Yamamoto N., Nogami S., Kaneuji T., Mitsugi S., Sakurai T., et al. Weekly teriparatide injections successfully treated advanced bisphosphonate-related osteonecrosis of the jaws. Osteoporos. Int. 2013;24:2365\u20132369. doi: 10.1007/s00198-013-2277-x.", "ArticleIdList": ["10.1007/s00198-013-2277-x", "PMC3706737", "23371327"]}, {"Citation": "Ohbayashi Y., Miyake M., Sawai F., Minami Y., Iwasaki A., Matsui Y. Adjunct teriparatide therapy with monitoring of bone turnover markers and bone scintigraphy for bisphosphonate-related osteonecrosis of the jaw. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. 2013;115:e31\u2013e37. doi: 10.1016/j.oooo.2012.09.006.", "ArticleIdList": ["10.1016/j.oooo.2012.09.006", "23246226"]}, {"Citation": "Yamachika E., Matsubara M., Ikeda A., Matsumura T., Moritani N., Iida S. Treatment of Osteonecrosis of the Jaw. J. Craniofacial Surg. 2015;26:e575\u2013e577. doi: 10.1097/SCS.0000000000002127.", "ArticleIdList": ["10.1097/SCS.0000000000002127", "26468825"]}, {"Citation": "Thumbigere-Math V., Michalowicz B.S., Hodges J.S., Tsai M.L., Swenson K.K., Rockwell L., Gopalakrishnan R. Periodontal disease as a risk factor for bisphosphonate-related osteonecrosis of the jaw. J. Periodontol. 2014;85:226\u2013233. doi: 10.1902/jop.2013.130017.", "ArticleIdList": ["10.1902/jop.2013.130017", "PMC3972496", "23786404"]}, {"Citation": "Mauceri R., Panzarella V., Maniscalco L., Bedogni A., Licata M.E., Albanese A., Toia F., Cumbo E.M.G., Mazzola G., Di Fede O., et al. Conservative Surgical Treatment of Bisphosphonate-Related Osteonecrosis of the Jaw with Er,Cr:YSGG Laser and Platelet-Rich Plasma: A Longitudinal Study. BioMed Res. Int. 2018;2018:1\u201310. doi: 10.1155/2018/3982540.", "ArticleIdList": ["10.1155/2018/3982540", "PMC6120338", "30211221"]}, {"Citation": "Hayashida S., Soutome S., Yanamoto S., Fujita S., Hasegawa T., Komori T., Kojima Y., Miyamoto H., Shibuya Y., Ueda N., et al. Evaluation of the Treatment Strategies for Medication-Related Osteonecrosis of the Jaws (MRONJ) and the Factors Affecting Treatment Outcome: A Multicenter Retrospective Study with Propensity Score Matching Analysis. J. Bone Min. Res. 2017;32:2022\u20132029. doi: 10.1002/jbmr.3191.", "ArticleIdList": ["10.1002/jbmr.3191", "28585700"]}, {"Citation": "Aljohani S., Troeltzsch M., Hafner S., Kaeppler G., Mast G., Otto S. Surgical treatment of medication-related osteonecrosis of the upper jaw: Case series. Oral Dis. 2019;25:497\u2013507. doi: 10.1111/odi.12992.", "ArticleIdList": ["10.1111/odi.12992", "30325561"]}, {"Citation": "Schiodt M., Vadhan-Raj S., Chambers M.S., Nicolatou-Galitis O., Politis C., Coropciuc R., Fedele S., Jandial D., Zhang J., Ma H., et al. A multicenter case registry study on medication-related osteonecrosis of the jaw in patients with advanced cancer. Support. Care Cancer. 2018;26:1905\u20131915. doi: 10.1007/s00520-017-4003-2.", "ArticleIdList": ["10.1007/s00520-017-4003-2", "PMC5919994", "29275525"]}, {"Citation": "Ristow O., R\u00fcckschlo\u00df T., M\u00fcller M., Berger M., Kargus S., Pautke C., Engel M., Hoffmann J., Freudlsperger C. Is the conservative non-surgical management of medication-related osteonecrosis of the jaw an appropriate treatment option for early stages? A long-term single-center cohort study. J. Cranio-Maxillofacial Surg. 2019;47:491\u2013499. doi: 10.1016/j.jcms.2018.12.014.", "ArticleIdList": ["10.1016/j.jcms.2018.12.014", "30642734"]}, {"Citation": "Ruggiero S.L., Dodson T.B., Assael L.A., Landesberg R., Marx R.E., Mehrotra B. American Association of Oral and Maxillofacial Surgeons Position Paper on Bisphosphonate-Related Osteonecrosis of the Jaws\u20142009 Update. J. Oral Maxillofac. Surg. 2009;67:2\u201312. doi: 10.1016/j.joms.2009.01.009.", "ArticleIdList": ["10.1016/j.joms.2009.01.009", "19371809"]}, {"Citation": "Ruggiero S.L., Dodson T.B., Fantasia J., Goodday R., Aghaloo T., Mehrotra B., O\u2019Ryan F. American Association of Oral and Maxillofacial Surgeons Position Paper on Medication-Related Osteonecrosis of the Jaw\u20142014 Update. J. Oral Maxillofac. Surg. 2014;72:1938\u20131956. doi: 10.1016/j.joms.2014.04.031.", "ArticleIdList": ["10.1016/j.joms.2014.04.031", "25234529"]}, {"Citation": "Mozzati M., Gallesio G., Arata V., Pol R., Scoletta M. Platelet-rich therapies in the treatment of intravenous bisphosphonate-related osteonecrosis of the jaw: A report of 32 cases. Oral Oncol. 2012;48:469\u2013474. doi: 10.1016/j.oraloncology.2011.12.004.", "ArticleIdList": ["10.1016/j.oraloncology.2011.12.004", "22265335"]}, {"Citation": "Bocanegra-P\u00e9rez S., Vicente-Barrero M., Knezevic M., Castellano-Navarro J., Bocanegra E.R., Rodr\u00edguez-Millares J., P\u00e9rez-Plasencia D., Ramos-Mac\u00edas A. Use of platelet-rich plasma in the treatment of bisphosphonate-related osteonecrosis of the jaw. Int. J. Oral Maxillofac. Surg. 2012;41:1410\u20131415. doi: 10.1016/j.ijom.2012.04.020.", "ArticleIdList": ["10.1016/j.ijom.2012.04.020", "22647765"]}, {"Citation": "Park J.-H., Kim J.-W., Kim S.-J. Does the Addition of Bone Morphogenetic Protein 2 to Platelet-Rich Fibrin Improve Healing After Treatment for Medication-Related Osteonecrosis of the Jaw? J. Oral Maxillofac. Surg. 2017;75:1176\u20131184. doi: 10.1016/j.joms.2016.12.005.", "ArticleIdList": ["10.1016/j.joms.2016.12.005", "28042979"]}, {"Citation": "Anitua E., Bego\u00f1a L., Orive G. Treatment of hemimandibular paresthesia in a patient with bisphosphonate-related osteonecrosis of the jaw (BRONJ) by combining surgical resection and PRGF-Endoret. Br. J. Oral Maxillofac. Surg. 2013;51:e272\u2013e274. doi: 10.1016/j.bjoms.2012.08.018.", "ArticleIdList": ["10.1016/j.bjoms.2012.08.018", "23201057"]}, {"Citation": "Pelaz A., Junquera L., Gallego L., Garcia-Consuegra L., Gomez C. Alternative treatments for oral bisphosphonate-related osteonecrosis of the jaws: A pilot study comparing fibrin rich in growth factors and teriparatide. Med. Oral Patol. Oral Cir. Bucal. 2014;19:e320\u2013e326. doi: 10.4317/medoral.19458.", "ArticleIdList": ["10.4317/medoral.19458", "PMC4119305", "24608203"]}, {"Citation": "Dinc\u0103 O., Zurac S., St\u0103niceanu F., Bucur M.B., Bodnar D.C., Vl\u0103dan C., Bucur A. Clinical and histopathological studies using fibrin-rich plasma in the treatment of bisphosphonate-related osteonecrosis of the jaw. Rom. J. Morphol. Embryol. Rev. Roum. Morphol. Embryol. 2014;55:961\u2013964.", "ArticleIdList": ["25329128"]}, {"Citation": "N\u00f8rholt S., Hartlev J. Surgical treatment of osteonecrosis of the jaw with the use of platelet-rich fibrin: A prospective study of 15 patients. Int. J. Oral Maxillofac. Surg. 2016;45:1256\u20131260. doi: 10.1016/j.ijom.2016.04.010.", "ArticleIdList": ["10.1016/j.ijom.2016.04.010", "27179556"]}, {"Citation": "Soydan S.S., Uckan S. Management of Bisphosphonate-Related Osteonecrosis of the Jaw With a Platelet-Rich Fibrin Membrane: Technical Report. J. Oral Maxillofac. Surg. 2014;72:322\u2013326. doi: 10.1016/j.joms.2013.07.027.", "ArticleIdList": ["10.1016/j.joms.2013.07.027", "24075235"]}, {"Citation": "Tsai L.-L., Huang Y.-F., Chang Y.-C. Treatment of bisphosphonate-related osteonecrosis of the jaw with platelet-rich fibrin. J. Formos. Med. Assoc. 2016;115:585\u2013586. doi: 10.1016/j.jfma.2015.10.005.", "ArticleIdList": ["10.1016/j.jfma.2015.10.005", "26596688"]}, {"Citation": "Maluf G., de Pinho M.C., da Cunha SR de B., Santos PS da S., Fregnani E.R. Surgery combined with lprf in denosumab osteonecrosis of the jaw: Case report. Braz. Dent. J. 2016;27:353\u2013358. doi: 10.1590/0103-6440201600662.", "ArticleIdList": ["10.1590/0103-6440201600662", "27224573"]}, {"Citation": "G\u00f6nen Z.B., Asan C.Y. Treatment of bisphosphonate-related osteonecrosis of the jaw using platelet-rich fibrin. CRANIO. 2016;35:332\u2013336. doi: 10.1080/08869634.2016.1203093.", "ArticleIdList": ["10.1080/08869634.2016.1203093", "27363584"]}, {"Citation": "de Castro M.S., Ribeiro N.V., de Carli M.L., Pereira A.A.C., Sperandio F.F., Hanemann J.A.C. Photodynamically dealing with bisphosphonate-related osteonecrosis of the jaw: Successful case reports. Photodiagnosis Photodyn Ther. 2016;16:72\u201375. doi: 10.1016/j.pdpdt.2016.08.007.", "ArticleIdList": ["10.1016/j.pdpdt.2016.08.007", "27585753"]}, {"Citation": "Lee J.-J., Cheng S.-J., Jeng J.-H., Chiang C.-P., Lau H.-P., Kok S.-H. Successful treatment of advanced bisphosphonate-related osteonecrosis of the mandible with adjunctive teriparatide therapy. Head Neck. 2010;33:1366\u20131371. doi: 10.1002/hed.21380.", "ArticleIdList": ["10.1002/hed.21380", "20310042"]}, {"Citation": "Jung J., Yoo H.-Y., Kim G.-T., Lee J.-W., Lee Y.-A., Kim D.-Y., Kwon Y.-D. Short-Term Teriparatide and Recombinant Human Bone Morphogenetic Protein-2 for Regenerative Approach to Medication-Related Osteonecrosis of the Jaw: A Preliminary Study. J. Bone Miner. Res. 2017;32:2445\u20132452. doi: 10.1002/jbmr.3237.", "ArticleIdList": ["10.1002/jbmr.3237", "28815779"]}, {"Citation": "Gonz\u00e1lvez-Garc\u00eda M., Rodr\u00edguez-Lozano F.J., Villanueva V., Segarra-Fenoll D., Rodriguez-Gonzalez M.A., O\u00f1ate-S\u00e1nchez R., Blanquer M., Moraleda J.M. Cell Therapy in Bisphosphonate-Related Osteonecrosis of the Jaw. J. Craniofacial Surg. 2013;24:e226\u2013e228. doi: 10.1097/SCS.0b013e3182869968.", "ArticleIdList": ["10.1097/SCS.0b013e3182869968", "23714970"]}, {"Citation": "Da Guarda M.G., Paraguass\u00fa G.M., Cerqueira N.S., Cury P.R., Farias J.G., Ramalho L.M.P. Laser GaAlAs (\u03bb860nm) photobiomodulation for the treatment of bisphosphonate-induced osteonecrosis of the jaw. Photomed. Laser Surg. 2012;30:293\u2013297. doi: 10.1089/pho.2011.3219.", "ArticleIdList": ["10.1089/pho.2011.3219", "22509722"]}, {"Citation": "Altay M.A., Tasar F., Tosun E., Kan B. Low-Level Laser Therapy Supported Surgical Treatment of Bisphosphonate Related Osteonecrosis of Jaws: A Retrospective Analysis of 11 Cases. Photomed. Laser Surg. 2014;32:468\u2013475. doi: 10.1089/pho.2014.3742.", "ArticleIdList": ["10.1089/pho.2014.3742", "25045921"]}, {"Citation": "Atalay B., Yalcin S., Emes Y., Aktas I., Aybar B., Issever H., Mandel N.M., Cetin O., Oncu B. Bisphosphonate-related osteonecrosis: Laser-assisted surgical treatment or conventional surgery? Lasers Med. Sci. 2011;26:815\u2013823. doi: 10.1007/s10103-011-0974-2.", "ArticleIdList": ["10.1007/s10103-011-0974-2", "21809068"]}, {"Citation": "Vescovi P., Manfredi M., Merigo E., Guidotti R., Meleti M., Pedrazzi G., Fornaini C., Bonanini M., Ferri T., Nammour S. Early Surgical Laser-Assisted Management of Bisphosphonate-Related Osteonecrosis of the Jaws (BRONJ): A Retrospective Analysis of 101 Treated Sites with Long-Term Follow-Up. Photomed. Laser Surg. 2012;30:5\u201313. doi: 10.1089/pho.2010.2955.", "ArticleIdList": ["10.1089/pho.2010.2955", "22054203"]}, {"Citation": "Vescovi P., Merigo E., Meleti M., Manfredi M., Guidotti R., Nammour S. Bisphosphonates-related osteonecrosis of the jaws: A concise review of the literature and a report of a single-centre experience with 151 patients. J. Oral Pathol. Med. 2011;41:214\u2013221. doi: 10.1111/j.1600-0714.2011.01091.x.", "ArticleIdList": ["10.1111/j.1600-0714.2011.01091.x", "21958312"]}, {"Citation": "Vescovi P., Giovannacci I., Otto S., Manfredi M., Merigo E., Fornaini C., Nammour S., Meleti M. Medication-Related Osteonecrosis of the Jaw: An Autofluorescence-Guided Surgical Approach Performed with Er:YAG Laser. Photomed. Laser Surg. 2015;33:437\u2013442. doi: 10.1089/pho.2015.3927.", "ArticleIdList": ["10.1089/pho.2015.3927", "26226174"]}, {"Citation": "Martins M.A.T., Martins M.D., LaScala C.A., Curi M.M., Migliorati C.A., Tenis C.A., Marques M. Association of laser phototherapy with PRP improves healing of bisphosphonate-related osteonecrosis of the jaws in cancer patients: A preliminary study. Oral Oncol. 2012;48:79\u201384. doi: 10.1016/j.oraloncology.2011.08.010.", "ArticleIdList": ["10.1016/j.oraloncology.2011.08.010", "21940198"]}, {"Citation": "Agrillo A., Filiaci F., Ramieri V., Riccardi E., Quarato D., Rinna C., Gennaro P., Cascino F., Mitro V., Ungari C. Bisphosphonate-related osteonecrosis of the jaw (BRONJ): 5 year experience in the treatment of 131 cases with ozone therapy. Eur. Rev. Med. Pharmacol. Sci. 2012;16:1741\u20131747.", "ArticleIdList": ["23161050"]}, {"Citation": "Al-Zoman K.H., Albazie S., Robert A.A., Baskaradoss J.K., Alsuwyed A.S., Ciancio S., Al-Mubarak S. Surgical management of bisphosphonate-related osteonecrosis of the jaw: Report of three cases. J. Palliat. Care. 2013;29:52\u201357. doi: 10.1177/082585971302900109.", "ArticleIdList": ["10.1177/082585971302900109", "23614172"]}, {"Citation": "Fatema C.N., Sato J., Yamazaki Y., Hata H., Hattori N., Shiga T., Tamaki N., Kitagawa Y. FDG-PET may predict the effectiveness of hyperbaric oxygen therapy in a patient with bisphosphonate-related osteonecrosis of the jaw: Report of a case. Odontology. 2013;103:105\u2013108. doi: 10.1007/s10266-013-0129-y.", "ArticleIdList": ["10.1007/s10266-013-0129-y", "23907202"]}, {"Citation": "Freiberger J.J., Padilla-Burgos R., McGraw T., Suliman H.B., Kraft K.H., Stolp B.W., Moon R.E., Piantadosi C.A. What Is the Role of Hyperbaric Oxygen in the Management of Bisphosphonate-Related Osteonecrosis of the Jaw: A Randomized Controlled Trial of Hyperbaric Oxygen as an Adjunct to Surgery and Antibiotics. J. Oral Maxillofac. Surg. 2012;70:1573\u20131583. doi: 10.1016/j.joms.2012.04.001.", "ArticleIdList": ["10.1016/j.joms.2012.04.001", "22698292"]}, {"Citation": "Ripamonti C., Maniezzo M., Boldini S., Pessi M., Mariani L., Cislaghi E. Efficacy and tolerability of medical ozone gas insufflations in patients with osteonecrosis of the jaw treated with bisphosphonates\u2014Preliminary data: Medical ozone gas insufflation in treating ONJ lesions. J. Bone Oncol. 2012;1:81\u201387. doi: 10.1016/j.jbo.2012.08.001.", "ArticleIdList": ["10.1016/j.jbo.2012.08.001", "PMC4723354", "26909261"]}, {"Citation": "Brozoski M.A., Traina A.A., Deboni M.C.Z., Marques M.M., Nacl\u00e9rio-Homem M da G. Bisphosphonate-related osteonecrosis of the jaw. Rev. Bras. Reumatol. 2020;52:265\u2013270. doi: 10.1590/S0482-50042012000200010.", "ArticleIdList": ["10.1590/S0482-50042012000200010", "22460415"]}, {"Citation": "Kwon Y.-D., Lee D.-W., Choi B.-J., Lee J.-W., Kim D.-Y. Short-term teriparatide therapy as an adjunctive modality for bisphosphonate-related osteonecrosis of the jaws. Osteoporos. Int. 2012;23:2721\u20132725. doi: 10.1007/s00198-011-1882-9.", "ArticleIdList": ["10.1007/s00198-011-1882-9", "22218418"]}, {"Citation": "Doh R.-M., Park H.-J., Rhee Y., Kim H.S., Huh J., Park W. Teriparatide Therapy for Bisphosphonate-Related Osteonecrosis of the Jaw Associated With Dental Implants. Implant. Dent. 2015;24:222\u2013226. doi: 10.1097/ID.0000000000000232.", "ArticleIdList": ["10.1097/ID.0000000000000232", "25734949"]}, {"Citation": "Kakehashi H., Ando T., Minamizato T., Nakatani Y., Kawasaki T., Ikeda H., Kuroshima S., Kawakami A., Asahina I. Administration of teriparatide improves the symptoms of advanced bisphosphonate-related osteonecrosis of the jaw: Preliminary findings. Int. J. Oral Maxillofac. Surg. 2015;44:1558\u20131564. doi: 10.1016/j.ijom.2015.07.018.", "ArticleIdList": ["10.1016/j.ijom.2015.07.018", "26304604"]}, {"Citation": "Rahim I., Salt S., Heliotis M. Successful long-term mandibular reconstruction and rehabilitation using non-vascularised autologous bone graft and recombinant human BMP-7 with subsequent endosseous implant in a patient with bisphosphonate-related osteonecrosis of the jaw. Br. J. Oral Maxillofac. Surg. 2015;53:870\u2013874. doi: 10.1016/j.bjoms.2015.08.006.", "ArticleIdList": ["10.1016/j.bjoms.2015.08.006", "26392134"]}, {"Citation": "Montebugnoli L., Felicetti L., Gissi D.B., Pizzigallo A., Pelliccioni G.A., Marchetti C. Biphosphonate-associated osteonecrosis can be controlled by nonsurgical management. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endodontology. 2007;104:473\u2013477. doi: 10.1016/j.tripleo.2007.01.008.", "ArticleIdList": ["10.1016/j.tripleo.2007.01.008", "17482847"]}, {"Citation": "de Souza P\u00f3voa R.C., Marlier\u00e8 D.A.A., da Silveira H.M., Pires F.R. Denosumab-related osteonecrosis of the jaws: Successful management with a conservative surgical approach. Spec. Care Dent. 2016;36:231\u2013236. doi: 10.1111/scd.12168.", "ArticleIdList": ["10.1111/scd.12168", "26859582"]}, {"Citation": "Ribeiro N.R.B., Silva L.D.F., Santana D.M., Nogueira R.L.M. Bisphosphonate-Related Osteonecrosis of the Jaw After Tooth Extraction. J. Craniofacial Surg. 2015;26:e606\u2013e608. doi: 10.1097/SCS.0000000000002051.", "ArticleIdList": ["10.1097/SCS.0000000000002051", "26468839"]}, {"Citation": "de Souza Faloni A.P., Queiroz T.P., Lia RC C., Cerri P.S., Margonar R., de Souza Rastelli A.N., Marcantonio E. Accurate approach in the treatment of oral bisphosphonate-related jaw osteonecrosis. J. Craniofac. Surg. 2011;22:2185\u20132190. doi: 10.1097/SCS.0b013e318232410b.", "ArticleIdList": ["10.1097/SCS.0b013e318232410b", "22075816"]}, {"Citation": "Lee L.-W., Hsiao S.-H., Chen L.-K. Clinical treatment outcomes for 40 patients with bisphosphonates-related osteonecrosis of the jaws. J. Formos. Med. Assoc. 2014;113:166\u2013172. doi: 10.1016/j.jfma.2012.04.010.", "ArticleIdList": ["10.1016/j.jfma.2012.04.010", "24630034"]}, {"Citation": "Graziani F., Vescovi P., Campisi G., Favia G., Gabriele M., Gaeta G.M., Gennai S., Goia F., Miccoli M., Peluso F., et al. Resective Surgical Approach Shows a High Performance in the Management of Advanced Cases of Bisphosphonate-Related Osteonecrosis of the Jaws: A Retrospective Survey of 347 Cases. J. Oral Maxillofac. Surg. 2012;70:2501\u20132507. doi: 10.1016/j.joms.2012.05.019.", "ArticleIdList": ["10.1016/j.joms.2012.05.019", "22883322"]}, {"Citation": "Duarte L.F.M., Alonso K., Basso E.C., Dib L.L. Surgical Treatment of Bisphosphonate-Related Osteonecrosis of the Jaws with the Use of Buccal Fat Pad: Case Report. Braz. Dent. J. 2015;26:317\u2013320. doi: 10.1590/0103-6440201301918.", "ArticleIdList": ["10.1590/0103-6440201301918", "26200161"]}, {"Citation": "Berrone M., Florindi F.U., Carbone V., Aldiano C., Pentenero M. Stage 3 Medication-Related Osteonecrosis of the Posterior Maxilla: Surgical Treatment Using a Pedicled Buccal Fat Pad Flap: Case Reports. J. Oral Maxillofac. Surg. 2015;73:2082\u20132086. doi: 10.1016/j.joms.2015.06.165.", "ArticleIdList": ["10.1016/j.joms.2015.06.165", "26183009"]}, {"Citation": "Lopes R.N., Rabelo G., Rocha A.C., Carvalho P.A.G., Alves F.A. Surgical Therapy for Bisphosphonate-Related Osteonecrosis of the Jaw: Six-Year Experience of a Single Institution. J. Oral Maxillofac. Surg. 2015;73:1288\u20131295. doi: 10.1016/j.joms.2015.01.008.", "ArticleIdList": ["10.1016/j.joms.2015.01.008", "25871903"]}, {"Citation": "Hewson I., Syme D., Bruscino-Raiola F. Radical surgical treatment of bisphosphonate related osteonecrosis of the jaw. Aust. Dent. J. 2012;57:227\u2013230. doi: 10.1111/j.1834-7819.2012.01675.x.", "ArticleIdList": ["10.1111/j.1834-7819.2012.01675.x", "22624766"]}, {"Citation": "Ghazali N., Collyer J., Tighe J. Hemimandibulectomy and vascularized fibula flap in bisphosphonate-induced mandibular osteonecrosis with polycythaemia rubra vera. Int. J. Oral Maxillofac. Surg. 2013;42:120\u2013123. doi: 10.1016/j.ijom.2012.03.019.", "ArticleIdList": ["10.1016/j.ijom.2012.03.019", "22520725"]}, {"Citation": "Hanasono M.M., Militsakh O., Richmon J.D., Rosenthal E.L., Wax M.K. Mandibulectomy and Free Flap Reconstruction for Bisphosphonate-Related Osteonecrosis of the Jaws. JAMA Otolaryngol. Neck Surg. 2013;139:1135\u20131142. doi: 10.1001/jamaoto.2013.4474.", "ArticleIdList": ["10.1001/jamaoto.2013.4474", "24051498"]}, {"Citation": "Yarom N., Shapiro C.L., Peterson D.E., Van Poznak C.H., Bohlke K., Ruggiero S.L., Migliorati C.A., Khan A., Morrison A., Anderson H., et al. Medication-related osteonecrosis of the jaw: MASCC/ISOO/ASCO clinical practice guideline. J. Clin. Oncol. 2019;37:2270\u20132290. doi: 10.1200/JCO.19.01186.", "ArticleIdList": ["10.1200/JCO.19.01186", "31329513"]}, {"Citation": "Campisi G., Mauceri R., Bertoldo F., Bettini G., Biasotto M., Colella G., Consolo U., Di Fede O., Favia G., Fusco V., et al. Medication-Related Osteonecrosis of Jaws (MRONJ) Prevention and Diagnosis: Italian Consensus Update 2020. Int. J. Environ. Res. Public Health. 2020;17:5998. doi: 10.3390/ijerph17165998.", "ArticleIdList": ["10.3390/ijerph17165998", "PMC7460511", "32824826"]}, {"Citation": "Wilde F., Heufelder M., Winter K., Hendricks J., Frerich B., Schramm A., Hemprich A. The role of surgical therapy in the management of intravenous bisphosphonates-related osteonecrosis of the jaw. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endodontology. 2011;111:153\u2013163. doi: 10.1016/j.tripleo.2010.04.015.", "ArticleIdList": ["10.1016/j.tripleo.2010.04.015", "20674411"]}, {"Citation": "Carlson E.R., Basile J.D. The Role of Surgical Resection in the Management of Bisphosphonate-Related Osteonecrosis of the Jaws. J. Oral Maxillofac. Surg. 2009;67:85\u201395. doi: 10.1016/j.joms.2009.01.006.", "ArticleIdList": ["10.1016/j.joms.2009.01.006", "19371819"]}, {"Citation": "Shintani T., Hayashido Y., Mukasa H., Akagi E., Hoshino M., Ishida Y., Hamana T., Okamoto K., Kanda T., Koizumi K., et al. Comparison of the prognosis of bisphosphonate-related osteonecrosis of the jaw caused by oral and intravenous bisphosphonates. Int. J. Oral Maxillofac. Surg. 2015;44:840\u2013844. doi: 10.1016/j.ijom.2015.03.013.", "ArticleIdList": ["10.1016/j.ijom.2015.03.013", "25861974"]}, {"Citation": "Choukroun J., Adda F., Schoeffler C., Vervelle A. Une opportunit\u00e9 en paro-implantologie: Le PRF. Implantodontie. 2001;42:e62."}, {"Citation": "Dohan D.M., Choukroun J., Diss A., Dohan S.L., Dohan A., Mouhyi J., Gogly B. Platelet-rich fibrin (PRF): A second-generation platelet concentrate. Part II: Platelet-related biologic features. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endodontology. 2006;101:e45\u2013e50. doi: 10.1016/j.tripleo.2005.07.009.", "ArticleIdList": ["10.1016/j.tripleo.2005.07.009", "16504850"]}, {"Citation": "Mour\u00e3o C.F.D.A.B., Calasans-Maia M.D., Del Fabbro M., Vieira F.L.D., Machado R., Capella R., Miron R.J., Alves G.G. The use of Platelet-rich Fibrin in the management of medication-related osteonecrosis of the jaw: A case series. J. Stomatol. Oral Maxillofac. Surg. 2020;121:84\u201389. doi: 10.1016/j.jormas.2019.02.011.", "ArticleIdList": ["10.1016/j.jormas.2019.02.011", "30794883"]}, {"Citation": "Antonelli A., Giudice A., Muraca D., Fortunato L. Usefulness of advanced-platelet rich fibrin (A-PRF) and injectable-platelet rich fibrin (i-PRF) in the management of a massive medication-related osteonecrosis of the jaw (MRONJ): A 5-years follow-up case report. Indian J. Dent. Res. 2020;31:813\u2013818. doi: 10.4103/ijdr.IJDR_689_19.", "ArticleIdList": ["10.4103/ijdr.IJDR_689_19", "33433526"]}, {"Citation": "Schubert M., Klatte I., Linek W., M\u00fcller B., D\u00f6ring K., Eckelt U., Hemprich A., Berger U., Hendricks J. The Saxon Bisphosphonate Register\u2013Therapy and prevention of bisphosphonate-related osteonecrosis of the jaws. Oral Oncol. 2012;48:349\u2013354. doi: 10.1016/j.oraloncology.2011.11.004.", "ArticleIdList": ["10.1016/j.oraloncology.2011.11.004", "22130456"]}, {"Citation": "Pechalova P., Bakardjiev A., Zaprianov Z., Vladimirov B., Poriazova E., Zheleva A., Hadjigeorgiev G., Goranova-Marinova V., Goranov S. Bisphosphonate-associated osteonecrosis of the jaws-report of three cases in bulgaria and review of the literature. Acta Clin. Croatica. 2011;50:273\u2013279.", "ArticleIdList": ["22263396"]}, {"Citation": "Gallego L., Junquera L., Pelaz A., Hernando J., Megias J. The use of pedicled buccal fat pad combined with sequestrectomy in bisphosphonate-related osteonecrosis of the maxilla. Med. Oral Patol. Oral Cir. Bucal. 2012;17:e236\u2013e241. doi: 10.4317/medoral.17422.", "ArticleIdList": ["10.4317/medoral.17422", "PMC3448310", "22143692"]}, {"Citation": "Fortuna G., Ruoppo E., Pollio A., Aria M., Adamo D., Leuci S., Orabona G.D., Mignogna M.D. Multiple myeloma vs. breast cancer patients with bisphosphonates-related osteonecrosis of the jaws: A comparative analysis of response to treatment and predictors of outcome. J. Oral Pathol. Med. 2011;41:222\u2013228. doi: 10.1111/j.1600-0714.2011.01095.x.", "ArticleIdList": ["10.1111/j.1600-0714.2011.01095.x", "22092390"]}, {"Citation": "De Santis G.C., Macedo L., Orellana M.D., Innocentini L.M.A.R., Ferrari T.C., Ricz H.M.A., Caruso S.R., Fernandes T.R., Covas D.T. Mesenchymal stromal cells administration for osteonecrosis of the jaw caused by bisphosphonate: Report of two cases. Acta Oncol. 2020;59:789\u2013792. doi: 10.1080/0284186X.2020.1730004.", "ArticleIdList": ["10.1080/0284186X.2020.1730004", "32079438"]}, {"Citation": "Bouland C., Meuleman N., Widelec J., Keiani-Mothlagh K., Voisin C., Lagneaux L., Philippart P. Case reports of medication-related osteonecrosis of the jaw (MRONJ) treated with uncultured stromal vascular fraction and L-PRF. J. Stomatol. Oral Maxillofac. Surg. 2021;122:212\u2013218. doi: 10.1016/j.jormas.2020.05.024.", "ArticleIdList": ["10.1016/j.jormas.2020.05.024", "32540361"]}, {"Citation": "Marconcini S., Denaro M., Cosola S., Gabriele M., Toti P., Mijiritsky E., Proietti A., Basolo F., Giammarinaro E., Covani U. Myofibroblast Gene Expression Profile after Tooth Extraction in the Rabbit. Materials. 2019;12:3697. doi: 10.3390/ma12223697.", "ArticleIdList": ["10.3390/ma12223697", "PMC6888118", "31717520"]}, {"Citation": "Marconcini S., Giammarinaro E., Cosola S., Genovesi A.M., Covani U. Mandibular Osteonecrosis Associated with Antacid Therapy (Esomeprazole) Eur. J. Case Rep. Intern. Med. 2019:6. doi: 10.12890/2019_001279.", "ArticleIdList": ["10.12890/2019_001279", "PMC6822666", "31742205"]}, {"Citation": "Bedogni A., Fedele S., Bedogni G., Scoletta M., Favia G., Colella G., Agrillo A., Bettini G., Di Fede O., Oteri G., et al. Staging of osteonecrosis of the jaw requires computed tomography for accurate definition of the extent of bony disease. Br. J. Oral Maxillofac. Surg. 2014;52:603\u2013608. doi: 10.1016/j.bjoms.2014.04.009.", "ArticleIdList": ["10.1016/j.bjoms.2014.04.009", "24856927"]}], "ReferenceList": []}], "History": [{"Year": "2021", "Month": "6", "Day": "29"}, {"Year": "2021", "Month": "7", "Day": "30"}, {"Year": "2021", "Month": "8", "Day": "3"}, {"Year": "2021", "Month": "8", "Day": "27", "Hour": "1", "Minute": "19"}, {"Year": "2021", "Month": "8", "Day": "28", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "9", "Day": "4", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "8", "Day": "10"}], "PublicationStatus": "epublish", "ArticleIdList": ["34444181", "PMC8392050", "10.3390/ijerph18168432", "ijerph18168432"]}}], "PubmedBookArticle": []}